UK markets close in 5 hours 17 minutes
  • FTSE 100

    -20.52 (-0.31%)
  • FTSE 250

    -49.63 (-0.24%)
  • AIM

    +9.02 (+0.75%)

    +0.0027 (+0.24%)

    +0.0012 (+0.09%)

    -245.21 (-1.00%)
  • CMC Crypto 200

    -5.04 (-0.74%)
  • S&P 500

    -11.60 (-0.30%)
  • DOW

    -179.02 (-0.57%)

    +0.53 (+1.01%)

    +6.40 (+0.34%)
  • NIKKEI 225

    +190.84 (+0.67%)

    +711.16 (+2.41%)
  • DAX

    -26.63 (-0.19%)
  • CAC 40

    -23.14 (-0.42%)

Global Eubiotics Market (2020 to 2025) - Featuring Biomin, Yara and Kemin Industries Among Others

Research and Markets
·8-min read

Dublin, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The "Eubiotics Market - Forecasts from 2020 to 2025" report has been added to's offering.

The eubiotics market is expected to grow at a compound annual growth rate of 7.74% over the forecast period to reach a market size of US$8.423 billion in 2025 from US$5.385 billion in 2019. The aforesaid projection is in part substantiated by awareness of the benefits like enhancing the immune system against bacterial or viral infections along with improving the digestive efficacy, paving the growth of the eubiotics market.

For example, the UK based international producer and distributor of natural animal feed additives for animal health, nutrition, and biosecurity Anpario PLC reportedly experienced a rise in sales by 13% to GBP16.2 million (US$20.6 million) and an improvement of 24% in adjusted EBITDA to GBP3.4 million in the six months to June 30. The sales growth was experienced among its phytogenics and acid-based eubiotics products especially in the regions of the Americas, Asia, and Europe. Further growing strategic investment like acquisitions as exemplified by the recent acquisition of Erber Group's Biomin and Romer Labs by Royal DSM, a global science-based company in nutrition, health, and sustainable living in October 2020 for an enterprise value of €980 million is also poised to facilitate the growth of the market.

In the context of the market, it is pertinent to note that the acquisition of Biomin which is Erber Group's specialty animal nutrition and health business and specializes in the management of gut health performance and mycotoxin risk reportedly augments DSM's expertise and the global recognition as a leading provider of solutions pertaining to animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on feed consumption efficiency, emissions reduction and better use of water and land. Earlier in November 2018, it was reported that Crina Digest relatively new poultry targeted essential oils product was launched by DSM as a part of its commitment to support the industry's efforts to reduce the use of antibiotics and foster proper digestive function that supports animal resilience and welfare. This product reportedly constitutes 3 essential compounds which are thymol, piperine, and eugenol which ensures a controlled release of bioactive along the gastrointestinal tract, significantly enhancing poultry digestive function.

The promising microencapsulation market which the author has reportedly forecasted to grow at a CAGR of 11.94% and reach a market size of US$16.594 billion in 2025 from an estimated value of US$8.434 billion in 2019 is also expected to drive the eubiotics markets. The controlled release of bioactive is facilitated by microencapsulation technologies. Further increasing investments in research and development to cater to the specific solution is also expected to throttle the growth of the market. Further regulatory measures like that of US Food & Drug Administration (FDA) initiative to reduce antimicrobial resistance with several programs, including the Veterinary Feed Directive (VFD) are also partly responsible for facilitating the demand for essential oils, organic acids, prebiotics, and probiotics as a successful replacement for antibiotics growth promoter (AGP), among others which in turn is poised to drive the growth of the eubiotics market.

The expanding global retail sector which is driven by increased consumption of processed food, among others is expected to drive the growth of the market. This is partly due to the increasing availability of disposable income and the growing rate of urbanization. Further growing consumer awareness is further leading to a surge in meat consumption that has been produced devoid of any antibiotics. Further, the prospect of the market is estimated to be promising considering the prospects of livestock outlook as per FAO. To this end, it is pertinent to note that global poultry and ovine meat production are estimated to grow. World ovine meat output is forecast to expand by nearly 1 % in 2020, to 16 million tons. The greater extent of the increase is expected to be concentrated in China with some modest growth which has been forecasted for Africa.

In China, production is forecast to register a 2.3 percent increase, capitalizing on the previous year's expansion of sheep and goat flocks, when high prices attracted more herders into the sector. In 2020 it has been estimated that global poultry meat production will be in the order of 137 million tons, which is reportedly an increase of 2.4 % in comparison to that registered in 2019. As far as China is concerned increases are expected due to the poultry meat output that is projected to expand gradually which would be buttressed by the comparatively firm demand, amid continuing high pig meat prices.

Key Topics Covered:

1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Eubiotics Market Analysis, by Type
5.1. Introduction
5.2. Enzymes
5.3. Essential Oils
5.4. Organic Acids
5.5. Prebiotics
5.6. Probiotics

6. Eubiotics Market Analysis, by Form
6.1. Introduction
6.2. Ashwagandha
6.3. Turmeric
6.4. Ginseng
6.5. Others

7. Eubiotics Market Analysis, by Function
7.1. Introduction
7.2. Gut Health
7.3. Immunity
7.4. Yield
7.5. Others

8. Eubiotics Market Analysis, by End-Use
8.1. Introduction
8.2. Aquatic Feed
8.3. Cattle Feed
8.4. Poultry Feed
8.5. Swine Feed
8.6. Others

9. Eubiotics Market Analysis, by Geography
9.1. Introduction
9.2. North America
9.2.1. North America Eubiotics Market, by Type, 2019 to 2025
9.2.2. North America Eubiotics Market, by Form, 2019 to 2025
9.2.3. North America Eubiotics Market, by Function, 2019 to 2025
9.2.4. North America Eubiotics Market, by End-Use, 2019 to 2025
9.2.5. By Country United States Canada Mexico
9.3. South America
9.3.1. South America Eubiotics Market, by Type, 2019 to 2025
9.3.2. South America Eubiotics Market, by Form, 2019 to 2025
9.3.3. South America Eubiotics Market, by Function, 2019 to 2025
9.3.4. South America Eubiotics Market, by End-Use, 2019 to 2025
9.3.5. By Country Brazil Argentina Others
9.4. Europe
9.4.1. Europe Eubiotics Market, by Type, 2019 to 2025
9.4.2. Europe Eubiotics Market, by Form, 2019 to 2025
9.4.3. Europe Eubiotics Market, by Function, 2019 to 2025
9.4.4. Europe Eubiotics Market, by End-Use, 2019 to 2025
9.4.5. By Country Germany United Kingdom France Italy Russia Others
9.5. Middle East and Africa
9.5.1. Middle East and Africa Eubiotics Market, by Type, 2019 to 2025
9.5.2. Middle East and Africa Eubiotics Market, by Form, 2019 to 2025
9.5.3. Middle East and Africa Eubiotics Market, by Function, 2019 to 2025
9.5.4. Middle East and Africa Eubiotics Market, by End-Use, 2019 to 2025
9.5.5. By Country Saudi Arabia South Africa Others
9.6. Asia-Pacific
9.6.1. Asia-Pacific Eubiotics Market, by Type, 2019 to 2025
9.6.2. Asia-Pacific Eubiotics Market, by Form, 2019 to 2025
9.6.3. Asia-Pacific Eubiotics Market, by Function, 2019 to 2025
9.6.4. Asia-Pacific Eubiotics Market, by End-Use, 2019 to 2025
9.6.5. By Country China Japan India Indonesia Others

10. Competitive Environment and Analysis
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix

11. Company Profiles
11.1. Bioresource International, Inc.
11.2. Dbc AG Products
11.3. Biomar (Schouw & Co.)
11.4. Phibro Animal Health Corporation
11.5. Adisseo (Bluestar Adisseo Co. Ltd)
11.6. Novus International (Mitsui & Co. Ltd.)
11.7. Biomin (Dsm)
11.8. Yara
11.9. Calpis Co. Ltd. (Asahi Group Holdings, Ltd.)
11.10. Kemin Industries, Inc.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900